Life Sciences Archives

FEATURED Life Sciences NEWS PRESS RELEASE

Texas Research Quarter Receives City of Plano Approval for Development Agreement Supporting Life Sciences Real Estate Project

City Council Approval Marks Key Step Toward a Public-Private Partnership to Establish Plano as a…

mmarschikAugust 27, 2024

FEATURED Life Sciences NEWS PRESS RELEASE

NexPoint Launches NexPoint Semiconductor Manufacturing DST Offering

DALLAS, October 19, 2023 /PRNewswire/ -- NexPoint, an alternative investment firm with $16.6 billion in assets under management, today announced…

PStewart@nexpoint.comOctober 19, 2023

FEATURED Life Sciences NEWS PRESS RELEASE

NexPoint Announces Co-investment in NexPoint Life Sciences II DST, Continuing Commitment to Life Sciences with a Focus on CDMOs and cGMP Facilities

DALLAS, Sept. 12, 2023 /PRNewswire/ -- NexPoint, a multibillion-dollar alternative investment platform, announces it has made an initial…

mmarschikSeptember 12, 2023

Life Sciences NEWS PRESS RELEASE

NexPoint’s Life Sciences Project in Plano, Texas Renamed Texas Research Quarter

DALLAS, May 18, 2023 /PRNewswire/ -- NexPoint, a multibillion-dollar alternative investment firm, today announced that its cutting-edge…

mmarschikMay 18, 2023

FEATURED Life Sciences NEWS PRESS RELEASE

NexPoint Expands Life Sciences Real Estate Footprint with Acquisition of Two Properties from Adare Pharma Solutions

Properties were indirectly acquired by NexPoint Life Sciences II DST, a Delaware statutory trust seeking to raise $42…

mmarschikMay 17, 2023

FEATURED Life Sciences NEWS PRESS RELEASE

Featured Video: Focus on Alternatives: Real Estate Investing in Life Sciences

In an interview with ADISA board member Greg Mausz, Nexpoint’s chief financial officer and executive…

mmarschikApril 27, 2023

FEATURED Life Sciences NEWS PRESS RELEASE

NexPoint Announces Proposal for TxS District, a 200-Acre Life Sciences District Centered at the Former EDS Campus in Plano, Texas

Proposed development would create a life science ecosystem with world-class lab, office, and therapeutic production…

mmarschikFebruary 7, 2023

Form CRS | Important Risk Disclosures | Privacy Policy

Before investing in any of the NexPoint funds, you should carefully consider the fund’s investment objectives, risks, charges, and expenses. A copy of a fund’s prospectus, which contains this and other information, is available on the fund’s website or by calling the shareholder services at (844) 485-9167.

Please read the prospectus carefully before investing. This website is neither an offer to sell nor a solicitation of an offer to buy any of the securities described herein. An investment in any of the NexPoint offerings involves risk, and there can be no assurance that the investment objectives will be met. Past performance does not guarantee future results.

NexPoint Securities, Inc., Member FINRA/SIPC, is the distributor for NexPoint products.

Brokercheck.FINRA.org

Life Sciences

Texas Research Quarter Receives City of Plano Approval for Development Agreement Supporting Life Sciences Real Estate Project

NexPoint Launches NexPoint Semiconductor Manufacturing DST Offering

NexPoint Announces Co-investment in NexPoint Life Sciences II DST, Continuing Commitment to Life Sciences with a Focus on CDMOs and cGMP Facilities

NexPoint’s Life Sciences Project in Plano, Texas Renamed Texas Research Quarter

NexPoint Expands Life Sciences Real Estate Footprint with Acquisition of Two Properties from Adare Pharma Solutions

Featured Video: Focus on Alternatives: Real Estate Investing in Life Sciences

NexPoint Announces Proposal for TxS District, a 200-Acre Life Sciences District Centered at the Former EDS Campus in Plano, Texas

Follow NexPoint on LinkedIn

Contact Us

$2.7 Billion